Peritoneal cancer is one of the more complex conditions in abdominal oncology because it affects the lining of the abdominal cavity and can involve multiple surfaces rather than a single organ. This makes diagnosis and treatment planning more demanding. Patients may experience abdominal swelling, pain, digestive changes, reduced appetite, or unexplained discomfort, though the pattern can vary widely. Proper evaluation is essential before choosing the right treatment strategy.
At Dr Ninad Katdare Cancer Surgeon in Mumbai, peritoneal cancer care is guided by the extent of disease, likely tumor origin, and whether surgery can offer meaningful benefit. In selected cases, CRS HIPEC is considered as an advanced cancer care option. This treatment combines cytoreductive surgery to remove visible disease with HIPEC surgery to target remaining microscopic cells using heated chemotherapy inside the abdominal cavity. For some patients, this creates a more comprehensive treatment pathway than conventional approaches alone.
Peritoneal disease may arise from colorectal, appendiceal, ovarian, or stomach-related cancers, which is why gastrointestinal cancer treatment planning and coordination with other specialists may also be part of care. What matters most is not only surgical skill but also judgment about timing, suitability, and long-term disease control. When treatment is explained clearly, patients are better prepared to make decisions that feel informed and realistic.
For expert assessment of peritoneal cancer and specialized abdominal oncology treatment, contact Dr Ninad Katdare, Cancer Surgeon in Mumbai.
